Creating edible materials to reduce exposure to harmful chemicals in food.
Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)
This study is working on creating safe, natural materials that can help reduce the harmful 'forever chemicals' (PFAS) in our food and water, making it better for your health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-11135044 on NIH RePORTER |
What this research studies
This research focuses on developing safe, edible sorbents that can help reduce dietary exposure to per- and polyfluoroalkyl substances (PFAS), commonly known as 'forever chemicals.' These substances are prevalent in the environment and can have serious health effects. The project aims to create multicomponent sorbents from natural materials that can effectively bind to PFAS in food and drinking water, thereby minimizing their absorption in the body. The research will involve laboratory studies to test the effectiveness of these sorbents in reducing PFAS levels.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who consume food and water potentially contaminated with PFAS, particularly those living in affected communities.
Not a fit: Patients who do not consume food or water with PFAS contamination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the health risks associated with PFAS exposure from diet.
How similar studies have performed: While the approach of using edible sorbents is innovative, similar strategies for reducing chemical exposures have shown promise in preliminary studies.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Wang, Meichen — University of Massachusetts Amherst
- Study coordinator: Wang, Meichen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.